34 / 74 · 1:10 · Original AXON film
FOXO4-DRI
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
FOXO4-DRI | Senescence research
Some damaged cells enter senescence and remain in tissue. FOXO4-DRI was designed to test whether a protein interaction helps certain senescent cells stay alive. [1]
CELL EXPERIMENTS | FOXO4 and p53
In the original study, the peptide disrupted an interaction involving FOXO4 and p53. Selected senescent cells then underwent programmed cell death in laboratory experiments. [1]
MOUSE MODELS | Not a human trial
Researchers also reported tissue-function changes in mouse models of aging and chemotherapy-related injury. These experiments tested particular models, not anti-aging treatment in people. [1]
MOUSE SAFETY SIGNAL | Context matters
A later study reported lung-circulation changes and loss of lung blood-vessel lining cells in mice engineered to overexpress the serotonin transporter and given FOXO4-DRI. This raises a model-specific safety concern; it does not quantify risk in people. [2]
Human outcomes remain unproven here
That distinction matters. A mechanism and animal results do not establish human rejuvenation, long-term safety or which people might benefit. Those remain separate research questions. [1] [2]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Baar et al. (2017): Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging →FOXO4-p53 mechanism and preclinical models. This is the primary paper, not the accompanying editorial.
- Born et al. (2023): Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression →Pulmonary hemodynamic alterations and pulmonary endothelial-cell loss in serotonin-transporter-overexpressing mice given FOXO4-DRI. Findings are model-specific and do not quantify human risk.
